File: Details of the programme will be revealed soon. AFP/Luis Robayo JOHANNESBURG - The South African Health Products Regulatory Authority (SAHPRA) has resolved to facilitate controlled access to Ivermectin for COVID-19 treatment. SAHPRA says it will be engaging with medical professionals and a guideline will be published soon. There has been much debate around the use of the drug. BREAKING: @SAHPRA1 has resolved to facilitate a controlled access programme of the ivermectin. South Africa's COVID-19 death toll is 41,797. Confirmed COVID-19 cases are now over 1.4 million. As of today, the total number of confirmed #COVID19 cases is 1 423 578, the total number of deaths is 41 797 and the total number of recoveries is 1 254 674. pic.twitter.com/T2klkhtStL